Coloplast A/S
OTC:CLPBF
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
DK |
Coloplast A/S
OTC:CLPBF
|
191.9B USD | 8.3 | ||
CH |
Alcon AG
SIX:ALC
|
39.5B CHF | 5 | ||
JP |
Hoya Corp
TSE:7741
|
6.6T JPY | 8.2 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 5 | ||
US |
Cooper Companies Inc
NYSE:COO
|
19.3B USD | 6 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.3B CNY | 13.5 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 58.8 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.7T KRW | 201.3 | |
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 1.9 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 3.9 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.3B USD | 2.2 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.